InvestorsHub Logo
Followers 17
Posts 769
Boards Moderated 0
Alias Born 07/15/2013

Re: Pyrrhonian post# 13127

Thursday, 06/12/2014 11:49:51 PM

Thursday, June 12, 2014 11:49:51 PM

Post# of 723480
More bad journalism. On June 11, 2014, Benzinga's Morning Market Makers reported, "Northwest Biotherapeutics (NASDAQ: NWBO) shares gained 6.82% to $6.12 after the company reported positive outcome of Phase IIIb COMPASS Trial." On June 10, 2014, The Wall Street Journal stated, "Avanir Pharmaceuticals Announces Positive Outcome of Phase IIIb COMPASS Trial: A Head-to-Head Study Comparing AVP-825 to Oral Sumatriptan for the Acute Treatment of Migraine."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News